LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Tom McLeer Joins Alphatec Spine
People In The News

Tom McLeer Joins Alphatec Spine

October 15, 2012 1 min read Premium comments

Advertisement

Tom McLeer Joins Alphatec Spine
Courtesy of Alphatec Spine

Thomas McLeer, formerly general manager of Spinal Operations for Pioneer Surgical, has accepted the post of Senior Vice President of U.S. Commercial Operations for Alphatec Spine.  In this post McLeer will be responsible for U.S. Sales and Marketing, Alphatec Spine’s Biologics Division and Research and Development. He will report to Les Cross, Alphatec’s chairman and Chief Executive Officer.

“We are pleased to have Tom join the Alphatec Spine team at this critical juncture of our growth, ” said Cross. “Tom’s appointment is an important next step for the company and its transformation into a market-driven and customer-focused organization. Integrating the teams from our U.S. commercial operations under a single point of leadership strengthens the company’s ability to deliver a continuous flow of successful new products that offer the latest in technology and deliver real value to surgeons, hospitals and patients. We look forward to Tom’s contributions to help Alphatec Spine achieve its growth objectives.”

Other posts held by McLeer include vice president of sales and marketing for Archus Orthopedics where he was responsible for creating a global strategy focused on growth and development for a newly created spinal implant segment. He also held executive-level positions at Spinal Concepts, Inc., Interpore Cross, Inc., and Zimmer, Inc.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy